Page last updated: 2024-08-21

methylazoxymethanol acetate and Brain Damage, Chronic

methylazoxymethanol acetate has been researched along with Brain Damage, Chronic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Featherstone, RE; Fletcher, PJ; Kapur, S; Nobrega, JN; Rizos, Z1
Beaulieu, M; Coyle, JT; Johnston, MV; Singer, H1

Other Studies

2 other study(ies) available for methylazoxymethanol acetate and Brain Damage, Chronic

ArticleYear
Gestational methylazoxymethanol acetate treatment impairs select cognitive functions: parallels to schizophrenia.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2007, Volume: 32, Issue:2

    Topics: Animals; Atrophy; Brain; Brain Damage, Chronic; Cognition Disorders; Discrimination Learning; Disease Models, Animal; Female; Learning Disabilities; Male; Methylazoxymethanol Acetate; Neuropsychological Tests; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Performance; Rats; Reinforcement, Psychology; Schizophrenia; Teratogens

2007
Development of central neurotransmitter-specified neuronal systems: implications for pediatric neuro-psychiatric disorders.
    Acta neurologica Scandinavica, 1984, Volume: 70, Issue:1

    Topics: Afferent Pathways; Animals; Brain Damage, Chronic; Cats; Central Nervous System; Cerebral Cortex; Chemical Phenomena; Chemistry; Child; Child, Preschool; G(M1) Ganglioside; gamma-Aminobutyric Acid; Gangliosidoses; Humans; Mental Disorders; Methylazoxymethanol Acetate; Nerve Tissue; Nervous System Diseases; Neurons; Neurotransmitter Agents; Rats; Sympathetic Nervous System; Synapses; Tourette Syndrome

1984